Translational Development Acquisition Corp.

TDAC · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$1,660$1,623$1,483-$8
Dep. & Amort.$0$0$1,027$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$112$24-$681
Other Non-Cash-$2,905-$1,907-$1,609-$122
Operating Cash Flow-$1,245-$171-$232-$811
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$174,225
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$1,250$0-$1,250$0
Investing Cash Flow$1,250$0-$1,250-$174,225
Financing Activities
Debt Repay.$0$0$0-$663
Stock Issued$0$0$0$169,050
Stock Repurch.$0$0$0$0
Dividends Paid$0-$1,844-$1,830-$125
Other Fin. Act.$1,277$1,844$2,528$6,989
Financing Cash Flow-$597$0$697$175,250
Forex Effect-$29$0$29$0
Net Chg. in Cash$12-$171$401$214
Supplemental Information
Beg. Cash$35$207$438$224
End Cash$47$35$207$438
Free Cash Flow-$1,245-$171-$232-$811